Pallas Capital Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
9,393
+6,793
| +261% | +$854K | 0.05% | 296 |
|
|
2025
Q1 | $288K | Sell |
2,600
-5,073
| -66% | -$561K | 0.01% | 596 |
|
|
2024
Q4 | $1.05M | Buy |
7,673
+1,225
| +19% | +$167K | 0.04% | 226 |
|
|
2024
Q3 | $745K | Buy |
6,448
+3,350
| +108% | +$387K | 0.03% | 276 |
|
|
2024
Q2 | $447K | Buy |
3,098
+647
| +26% | +$93.3K | 0.02% | 329 |
|
|
2024
Q1 | $338K | Buy |
+2,451
| New | +$338K | 0.01% | 342 |
|